In this study, we found that CMTM6 (CKLF like MARVEL transmembrane domain containing 6) plays a key role in promoting the expression of both CD58 and PD-L1, two immune checkpoint ligands with opposing functions, in tumor cells. The gene discussed is CD274; the disease is neoplasm.